Health care-associated invasive MRSA infections, 2005-2008

JAMA

Volumn 304, Issue 6, 2010, Pages 641-648

  Kallen, Alexander J ^a   Mu, Yi ^a   Bulens, Sandra ^a,b   Reingold, Arthur ^c   Petit, Susan ^d   Gershman, Ken ^e   Ray, Susan M ^f   Harrison, Lee H ^g   Lynfield, Ruth ^h   Dumyati, Ghinwa ⁱ   Townes, John M ^j   Schaffner, William ^k   Patel, Priti R ^a   Fridkin, Scott K ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Strategic Resources Management   (United States)

^e Colorado Department of Public Health and Environment ^*  (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁱ UNIVERSITY OF ROCHESTER   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; FEMALE; HEALTH CARE; HUMAN; IATROGENIC DISEASE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; UNITED STATES;

EID: 77955357246     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1115     Document Type: Article

References (31)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
2. Hidron AI, Edwards JR, Patel J, et al; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996-1011.
3. US Department of Health and Human Services. HHS action plan to prevent healthcare-associated infections. http://www.hhs.gov/ophs/initiatives/hai/ infection.html. Accessed October 28, 2009.
4. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43(8):971-978.
5. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):1149-1157.
6. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148(6):409-418.
7. Chaberny IF, Schwab F, Ziesing S, Suerbaum S, Gastmeier P. Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistent Staphylococcus aureus infections in a university hospital: an interrupted time-series analysis. J Antimicrob Chemother. 2008;62(6):1422-1429.
8. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol. 2007;28(10):1155-1161.
9. Muder RR, Cunningham C, McCray E, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillinresistant Staphylococcus aureus infections. Infect Control Hosp Epidemiol. 2008;29(8):702-708.
10. Burton DC, Edwards JR, Horan TC, Jernigan JA, Fridkin SK. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. JAMA. 2009;301(7):727-736.
11. Liebowitz LD. MRSA burden and interventions. Int J Antimicrob Agents. 2009;34(S3)(suppl 3):S11-S13.
12. Pearson A, Chronias A, Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S aureus (MSSA) bacteraemia in England. J Antimicrob Chemother. 2009;64(suppl 1):i11-i17.
13. Klevens RM, Morrison MA, Nadle J, et al; Active Bacterial Core surveillance (ABCs) MRSA Investigators. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763-1771.
14. Cohen AL, Calfee D, Fridkin SK, et al; Society for Healthcare Epidemiology of America and the Healthcare Infection Control Practices Advisory Committee. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol. 2008;29(10):901-913.
15. Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients - United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56(9):197-199.
16. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/ MDROGuideline2006.pdf. Accessed October 28, 2009.
17. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(suppl 1):S62-S80.
18. Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol. 2009;30(7):623-632.
19. Centers for Disease Control and Prevention (CDC). Reduction in central line-associated bloodstream infections among patients in intensive care units-Pennsylvania, April 2001-March 2005. MMWR Morb Mortal Wkly Rep. 2005;54(40):1013-1016.
20. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725-2732.
21. DeFrances CJ, Cullen KA, Kozak LJ. National hospital discharge survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. 2007;(165):1-209.
22. DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2006 National Hospital Discharge Survey. Hyattsville, MD: National Center for Health Statistics; 2008. Report 5.
23. King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144(5):309-317.
24. Moran GJ, Krishnadasan A, Gorwitz RJ, et al; EMERGEncy ID Net Study Group. Methicillin-resistant S aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666-674.
25. SeyboldU, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42(5):647-656.
26. Limbago B, Fosheim GE, Schoonover V, et al; Active Bacterial Core surveillance MRSA Investigators. Characterization ofmethicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol. 2009;47(5):1344-1351.
27. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis. 2008;46(11):1637-1646.
28. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Reports. http://www.cdc.gov/abcs/reports-findings/surv-reports. html. Accessed June 23, 2010.
29. Carrillo-Marquez MA, Hulten KG, Hammerman W, Mason EO, Kaplan SL. USA300 is the predominate genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009;28(12):1076-1080.
30. Enayet I, Nazeri A, Johnson LB, Riederer K, Pawlak J, Saravolatz LD. Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia. Clin Infect Dis. 2006;42(7):e57-e60.
31. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med. 2009;53(3):358-365.